Holen Sie sich die Stockscreener-App
2.2208
0.04%
-0.0092
Schlusskurs vom Vortag:
$2.23
Offen:
$2.25
24-Stunden-Volumen:
15,495
Relative Volume:
0.01
Marktkapitalisierung:
$4.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.28M
KGV:
-0.7378
EPS:
-3.01
Netto-Cashflow:
$-9.78M
1W Leistung:
+1.33%
1M Leistung:
+0.41%
6M Leistung:
-72.61%
1J Leistung:
-70.27%
1-Tages-Spanne:
$2.15
$2.25
1-Wochen-Bereich:
$2.15
$2.28
52-Wochen-Spanne:
$1.62
$14.67
Ensysce Biosciences Inc Stock (ENSC) Company Profile
Firmenname
Ensysce Biosciences Inc
Sektor
Branche
Telefon
(858) 263-4196
Adresse
7946 IVANHOE AVENUE, LA JOLLA
Vergleichen Sie ENSC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENSC
Ensysce Biosciences Inc
|
2.23 | 4.82M | 0 | -11.28M | -9.78M | -3.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.22 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.79 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
321.49 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
555.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.53 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Ensysce Biosciences Inc Aktie (ENSC) Neueste Nachrichten
Short Interest in Ensysce Biosciences, Inc. (NASDAQ:ENSC) Declines By 71.5% - Defense World
Leading Pain Experts Reveal New Opioid Abuse Prevention Technology at World's Largest Pain Conference - Stock Titan
(ENSC) On The My Stocks Page - news.stocktradersdaily.com
Ensysce Biosciences (NASDAQ:ENSC) Trading 1.7% Higher – Here’s What Happened - Defense World
ensysce biosciences appoints baker tilly as new auditor By Investing.com - Investing.com South Africa
ensysce biosciences appoints baker tilly as new auditor - Investing.com
Ensysce Flat on Receiving Grant - Baystreet.ca
Ensysce Biosciences secures additional $5.3M NIDA grant - Investing.com Australia
Ensysce Biosciences secures additional $5.3M NIDA grant By Investing.com - Investing.com Canada
Ensysce Biosciences (ENSC) Secures $5.3M Grant to Advance Opioid Development | ENSC Stock News - GuruFocus
Revolutionary Opioid With Built-in Overdose Protection Secures $5.3M NIH Grant After FDA Breakthrough Status - Stock Titan
Ensysce Biosciences (NASDAQ:ENSC) Raised to Hold at Wall Street Zen - Defense World
When (ENSC) Moves Investors should Listen - news.stocktradersdaily.com
Where are the Opportunities in (ENSC) - news.stocktradersdaily.com
Zacks Small Cap Analysts Boost Earnings Estimates for ENSC - Defense World
Ensysce Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Ensysce Biosciences Advances in Pain Relief Innovation - TipRanks
Revolutionary Opioid Treatment Proves Overdose-Proof in Clinical Trials, Secures Key Patent - Stock Titan
Ensysce Biosciences Bolsters Management Team with Regulatory Expert - Stock Titan
Head-To-Head Contrast: CV Sciences (OTCMKTS:CVSI) and Ensysce Biosciences (NASDAQ:ENSC) - Defense World
(ENSC) Trading Signals - news.stocktradersdaily.com
Ensysce Biosciences (ENSC) to Release Earnings on Friday - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Ensysce Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference - ACCESS Newswire
Ensysce Biosciences, Inc. Announces Closing of $3.0 Million Registered Direct Offering Priced at-the-Market Under NASDAQ Rules - ACCESS Newswire
Ensysce Biosciences Inc (ENSC) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Sete News
Ensysce Biosciences Secures $2.2M Funding Boost: Key Details on TAAP/MPAR Program Advancement - Stock Titan
Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - Benzinga
Ensysce Biosciences announces exercise of warrants for $2.2M gross proceeds - MSN
For Array Technologies Inc [ARRY], Analyst sees a rise to $7. What next? - dbtnews.com
Ensysce Biosciences (ENSC) Stock Surges on Patent News - GuruFocus
Ensysce Biosciences (ENSC) Secures $2.2 Million Through Warrant Exercise - GuruFocus
Ensysce Biosciences to raise $2.2 million through warrant exercise By Investing.com - Investing.com Canada
Ensysce Biosciences secures patent for OUD treatment By Investing.com - Investing.com South Africa
Ensysce Biosciences Stock Doubles In One Trading SessionHere's Why - AOL.com
Ensysce Biosciences to raise $2.2 million through warrant exercise - Investing.com Australia
Ensysce Biosciences Inc’s Shares Reel: -58.79% Quarterly Revenue Decline Amid 5.62M Market Cap - investchronicle.com
Dropbox Inc: Weathering Stock Market Storms with 7.92B Market Cap - investchronicle.com
Nuvation Bio Inc Inc. (NUVB) Price Performance: A Technical Analysis Perspective - investchronicle.com
Ensysce Biosciences Raises Fresh $2.2M Capital: H.C. Wainwright Backs Strategic Warrant Deal - Stock Titan
Sabre Corp (SABR) Stock: From Low to High in 52 Weeks - investchronicle.com
Analysts Are Recommending Ensysce Biosciences Inc (ENSC) As A Buy Candidate - Marketing Sentinel
Ensysce Biosciences Inc (NASDAQ:ENSC) stock: You might be surprised - uspostnews.com
Amentum Holdings Inc (AMTM) Shares Are Down -4.43% YTD - Marketing Sentinel
Crude Oil Falls Over 3%; Philip Morris Earnings Top Views - Benzinga
The Psychology of Altria Group Inc Inc. (MO) Price Performance: Understanding Market Sentiment - investchronicle.com
Ensysce (ENSC) Stock Sees Market Uplift Following New Patent Approval - Stocks Telegraph
The Psychology of Metsera Inc Inc. (MTSR) Price Performance: Understanding Market Sentiment - investchronicle.com
(ENSC) Technical Data - news.stocktradersdaily.com
Safety Shot Inc Inc. (SHOT) Price Performance: A Technical Analysis Perspective - investchronicle.com
Ensysce (ENSC) Advances PF614-MPAR in Overdose Protection Trial - GuruFocus
Finanzdaten der Ensysce Biosciences Inc-Aktie (ENSC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):